Junfei Xu

794 total citations
36 papers, 599 citations indexed

About

Junfei Xu is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Junfei Xu has authored 36 papers receiving a total of 599 indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 9 papers in Oncology and 6 papers in Cancer Research. Recurrent topics in Junfei Xu's work include Cancer Cells and Metastasis (6 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). Junfei Xu is often cited by papers focused on Cancer Cells and Metastasis (6 papers), RNA modifications and cancer (6 papers) and Cancer-related gene regulation (5 papers). Junfei Xu collaborates with scholars based in China. Junfei Xu's co-authors include Feiran Wang, Yasu Jiang, Jun Qin, Youlang Zhou, Zhixian He, Jian‐Guo Zhang, Lilin Ma, Haiyan Jiang, Ruixin Chen and Jinpeng Chen and has published in prestigious journals such as Scientific Reports, Atmospheric Environment and Frontiers in Plant Science.

In The Last Decade

Junfei Xu

32 papers receiving 592 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Junfei Xu China 15 394 252 148 74 45 36 599
Yipeng Yu China 11 408 1.0× 285 1.1× 81 0.5× 98 1.3× 50 1.1× 21 648
Zhongwei Lv China 20 805 2.0× 692 2.7× 101 0.7× 60 0.8× 49 1.1× 31 1.1k
Chunsheng Ni China 9 172 0.4× 94 0.4× 110 0.7× 41 0.6× 27 0.6× 20 320
Hope E. Burks United States 13 228 0.6× 100 0.4× 161 1.1× 28 0.4× 52 1.2× 27 417
Michał Jeleń Poland 13 203 0.5× 95 0.4× 153 1.0× 46 0.6× 18 0.4× 52 516
Bartłomiej Masojć Poland 18 552 1.4× 361 1.4× 307 2.1× 137 1.9× 47 1.0× 41 1.1k
Per Lund Germany 9 258 0.7× 126 0.5× 153 1.0× 23 0.3× 29 0.6× 9 453
Martin Scherzer Austria 10 305 0.8× 122 0.5× 298 2.0× 47 0.6× 69 1.5× 10 636
Xing Ren China 10 544 1.4× 153 0.6× 108 0.7× 46 0.6× 8 0.2× 31 724
Johannes Virtanen Finland 8 308 0.8× 100 0.4× 210 1.4× 108 1.5× 106 2.4× 9 655

Countries citing papers authored by Junfei Xu

Since Specialization
Citations

This map shows the geographic impact of Junfei Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Junfei Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Junfei Xu more than expected).

Fields of papers citing papers by Junfei Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Junfei Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Junfei Xu. The network helps show where Junfei Xu may publish in the future.

Co-authorship network of co-authors of Junfei Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Junfei Xu. A scholar is included among the top collaborators of Junfei Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Junfei Xu. Junfei Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
3.
Meng, Yuan, et al.. (2024). Correlation between Lactate Dehydrogenase to Albumin Ratio and the Prognosis of Patients with Cardiac Arrest. Reviews in Cardiovascular Medicine. 25(2). 65–65. 6 indexed citations
4.
Xu, Junfei, et al.. (2024). Multi-Agent Cross-Domain Collaborative Task Allocation Problem Based on Multi-Strategy Improved Dung Beetle Optimization Algorithm. Applied Sciences. 14(16). 7175–7175. 1 indexed citations
5.
Wang, Junhua, et al.. (2023). Z-Increments Online Supervisory System Based on Machine Vision for Laser Solid Forming. Micromachines. 14(8). 1558–1558. 2 indexed citations
6.
7.
Wang, Feiran, et al.. (2020). Identification of a six-gene signature associated with tumor mutation burden for predicting prognosis in patients with invasive breast carcinoma. Annals of Translational Medicine. 8(7). 453–453. 16 indexed citations
8.
Jiang, Yasu, et al.. (2017). miR-219-5p suppresses the proliferation and invasion of colorectal cancer cells by targeting calcyphosin. Oncology Letters. 13(3). 1319–1324. 15 indexed citations
9.
Chen, Jinpeng, Feiran Wang, Junfei Xu, et al.. (2016). The role of PAQR3 gene promoter hypermethylation in breast cancer and prognosis. Oncology Reports. 36(3). 1612–1618. 15 indexed citations
10.
Xu, Junfei, et al.. (2016). Abnormal expression of calcyphosine is associated with poor prognosis and cell biology function in colorectal cancer. OncoTargets and Therapy. 9. 477–477. 13 indexed citations
11.
Xu, Junfei, Feiran Wang, Haiyan Jiang, et al.. (2015). Properties and Clinical Relevance of Speckle-Type POZ Protein in Human Colorectal Cancer. Journal of Gastrointestinal Surgery. 19(8). 1484–1496. 27 indexed citations
12.
Wang, Zhiwei, Jun Qin, Jing Ke, et al.. (2015). Downregulation of microRNA-132 by DNA hypermethylation is associated with cell invasion in colorectal cancer. OncoTargets and Therapy. 8. 3639–3639. 36 indexed citations
13.
Shi, Rongfeng, et al.. (2014). NEDD9 overexpression correlates with the progression and prognosis in gastric carcinoma. Medical Oncology. 31(3). 852–852. 19 indexed citations
14.
Wang, Hua, Xiaobing Liu, Jiahui Chen, et al.. (2014). Decreased expression and prognostic role of cytoplasmic BRSK1 in human breast carcinoma: Correlation with Jab1 stability and PI3K/Akt pathway. Experimental and Molecular Pathology. 97(2). 191–201. 9 indexed citations
15.
Yu, Xiafei, Qichao Ni, Jinpeng Chen, et al.. (2014). Knocking down the expression of adenylate cyclase-associated protein 1 inhibits the proliferation and migration of breast cancer cells. Experimental and Molecular Pathology. 96(2). 188–194. 29 indexed citations
16.
Liu, Jianming, Lei Wang, Lilin Ma, et al.. (2013). Significantly increased expression of OCT4 and ABCG2 in spheroid body-forming cells of the human gastric cancer MKN-45 cell line. Oncology Letters. 6(4). 891–896. 10 indexed citations
17.
Liu, Xiaobing, Qichao Ni, Junfei Xu, et al.. (2013). Expression and prognostic role of SKIP in human breast carcinoma. Journal of Molecular Histology. 45(2). 169–180. 8 indexed citations
18.
Liu, Xiaobing, Hua Wang, Junfei Xu, et al.. (2013). The expression and prognosis of Emi1 and Skp2 in breast carcinoma: associated with PI3K/Akt pathway and cell proliferation. Medical Oncology. 30(4). 735–735. 27 indexed citations
19.
Liu, Jianming, Lilin Ma, Junfei Xu, et al.. (2012). Spheroid body-forming cells in the human gastric cancer cell line MKN-45 possess cancer stem cell properties. International Journal of Oncology. 42(2). 453–459. 96 indexed citations
20.
Jiang, Ying, Lin Zou, Chunhui Zhang, et al.. (2009). PPARγ and Wnt/β-Catenin pathway in human breast cancer: expression pattern, molecular interaction and clinical/prognostic correlations. Journal of Cancer Research and Clinical Oncology. 135(11). 1551–1559. 28 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026